Summary of Meet the drug developer taking on wildlife diseases

Overview of Meet the drug developer taking on wildlife diseases

In this Science Friday episode, host Flora Lichtman speaks with medicinal chemist Dr. Tim Cernak of the University of Michigan about using drug discovery to help endangered wildlife. Cernak argues that disease is a major, underappreciated driver of extinction—and that chemists can adapt modern drug-development tools to create safer, more targeted treatments for frogs, sea turtles, reptiles, and other species facing “mini pandemics” in the wild.

Key Takeaways

• Wildlife disease can be an extinction threat

  • Habitat loss, climate change, pollution, and invasive species all contribute to biodiversity decline, but disease is often the final push toward extinction.
  • Cernak highlights how some species are now so rare that a disease outbreak could wipe them out.

• Chemistry can be applied to ecosystem health

  • Cernak’s central question is: Can chemistry improve ecosystem health the way it improves human health?
  • He sees wildlife medicine as a logical extension of drug discovery, especially for diseases we already understand well.

• Modern drug discovery can move quickly

  • He points to the rapid development of COVID-era therapeutics as proof that effective medicines can be developed on accelerated timelines.
  • Advances in drug design and AI could make wildlife-targeted treatments more feasible.

Wildlife Diseases and Cases Discussed

Chytrid fungus in frogs

• Cernak describes chytrid as a global fungal disease devastating frog populations.
• It has been called one of the biggest pandemics on Earth, though it affects amphibians rather than humans.
• Existing antifungal treatments can work, but they have serious problems:
  • Toxicity / narrow dosing window
  • Immunosuppression, which may leave frogs vulnerable again after treatment
• His lab is exploring better, frog-specific options that are less toxic and easier to administer.

“Pebbles,” the Gila monster

• One of the episode’s most memorable examples is Pebbles, a Gila monster at the Creature Conservancy in Ann Arbor.
• She had a parasite infection severe enough that euthanasia was being considered.
• Cernak’s team found a treatment using paromomycin and worked with conservation partners to formulate and deliver it.
• Result: Pebbles has been in full remission for a year, regained weight, and is doing well.

Avian flu

• Cernak says his team is also studying avian influenza, especially mutant strains that are devastating wildlife populations.
• The goal is to identify or design drugs tailored to these specific outbreaks.

Sea turtles with cancer

• Sea turtles are another major focus.
• Some sea turtles develop widespread tumors that interfere with swimming, vision, and feeding, contributing to strandings.
• His team is screening cancer drugs and trying to develop treatments specifically designed for sea turtles, working with sea turtle hospitals and conservation groups.

Why This Work Matters

• Wildlife biology is different, but not irrelevant

  • Cernak emphasizes that animals often have very different physiology from humans, which creates real challenges in dosing and safety.
  • At the same time, the underlying biology can reveal pathways relevant to human medicine.

• Natural organisms have already inspired many medicines

  • The conversation recalls how Gila monster saliva helped lead to GLP-1 drugs like semaglutide.
  • Frogs and other animals have also contributed compounds that informed newer pain medicines.
  • Cernak frames this as a kind of reciprocity: since nature has given medicine so much, helping wildlife in return makes sense.

Notable Insights

• “Can we use chemistry to improve ecosystem health?”

  • This is Cernak’s guiding mission.

• “These technologies that have been bubbling up for drug discovery... got me thinking: what if there was disease in a turtle or a tree or a butterfly?”

  • He argues that the drug-discovery toolkit should not stop at human patients.

• Wildlife medicine can also expand scientific knowledge

  • Studying unusual species and diseases may uncover pathways and treatment strategies relevant to both conservation and human health.

Production Notes

• The episode is hosted by Flora Lichtman and produced by Rasha Aridi.
• The transcript includes a fundraising appeal and sponsor messages at the beginning and end, which are separate from the interview content.